SYNTHESIS, ANTI-HIV-1 AND HIV-2 ACTIVITY OF NAPHTHALENEDISULFONIC ACID-DERIVATIVES

被引:0
|
作者
MOHAN, P
SINGH, R
BABA, M
机构
[1] UNIV ILLINOIS,COLL PHARM,DEPT MED CHEM & PHARMACOGNOSY,CHICAGO,IL 60680
[2] FUKUSHIMA MED SCH,DEPT BACTERIOL,FUKUSHIMA 96012,JAPAN
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1990年 / 200卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:131 / MEDI
相关论文
共 50 条
  • [31] STRUCTURE-ACTIVITY RELATIONSHIP STUDIES WITH SYMMETRICAL NAPHTHALENESULFONIC ACID-DERIVATIVES - SYNTHESIS AND INFLUENCE OF SPACER AND NAPHTHALENESULFONIC ACID MOIETY ON ANTI-HIV-1 ACTIVITY (VOL 36, PG 1999, 1993)
    MOHAN, P
    WONG, MF
    VERMA, S
    HUANG, PP
    WICKRAMASINGHE, A
    BABA, M
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (25) : 4130 - 4130
  • [32] Anti-HIV-1 activity of inorganic polyphosphates
    Lorenz, B
    Leuck, J
    Kohl, D
    Muller, WEG
    Schroder, HC
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (02): : 110 - 118
  • [33] SYNTHESIS AND ACTIVITY OF NOVEL SUBSTITUTED PIPECOLINIC AMIDE DERIVATIVES AS HIV-1 AND HIV-2 PROTEASE INHIBITORS
    ANDERSON, PC
    BEAULIEU, P
    BOUSQUET, Y
    GILLARD, J
    GORYS, V
    GRANDMAITRE, C
    GUSE, I
    LAVALLEE, P
    PLAMONDON, L
    SOUCY, F
    TONG, L
    YOAKIM, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 39 - MEDI
  • [34] Anti-HIV-1 activity of leflunomide:: a comparison with mycophenolic acid and hydroxyurea
    Schläpfer, E
    Fischer, M
    Ott, P
    Speck, RF
    AIDS, 2003, 17 (11) : 1613 - 1620
  • [35] The anti-HIV-1 activity associated with saliva
    Shine, N
    Konopka, K
    Duzgunes, N
    JOURNAL OF DENTAL RESEARCH, 1997, 76 (02) : 634 - 640
  • [36] ANTI-HIV-1 ACTIVITY OF CURDLAN SULFATE
    AOKI, T
    KANEKO, Y
    TING, RCY
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 675 - 675
  • [37] Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: Implications for treatment and postexposure prophylaxis
    Witvrouw, M
    Pannecouque, C
    Switzer, WM
    Folks, TM
    De Clercq, E
    Heneine, W
    ANTIVIRAL RESEARCH, 2004, 62 (02) : A36 - A36
  • [38] Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis
    Witvrouw, M
    Pannecouque, C
    Switzer, WM
    Folks, TM
    De Clercq, E
    Heneine, W
    ANTIVIRAL THERAPY, 2004, 9 (01) : 57 - 65
  • [39] Anti-HIV-1 activity of benzothiadiazine dioxide
    Martinez, A
    Gil, C
    Castro, A
    Perez, C
    Witvrouw, M
    Pannecouque, C
    Balzarini, J
    De Clercq, E
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2001, 12 (06): : 347 - 351
  • [40] Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid
    Tyssen, David
    Wang, Ying-Ying
    Hayward, Joshua A.
    Agius, Paul A.
    DeLong, Kevin
    Aldunate, Muriel
    Ravel, Jacques
    Moench, Thomas R.
    Cone, Richard A.
    Tachedjian, Gilda
    MSPHERE, 2018, 3 (04):